Joel S. Marcus - Jun 14, 2024 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITCI	Restricted Stock Units	Award	$0	+2.95K		$0.00	2.95K	Jun 14, 2024	Common Stock	2.95K		Direct	F1, F2
transaction	ITCI	Stock Option (right to buy)	Award	$0	+4.32K		$0.00	4.32K	Jun 14, 2024	Common Stock	4.32K	$67.77	Direct

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock.
F2	On June 14, 2024, the reporting person was granted 2,951 restricted stock units, vesting on the first anniversary of the grant date (June 14, 2025).